CLPT ClearPoint Neuro, Inc. Stock Quote

CLPT [NASD]

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	2.80%	Shs Outstand	15.72M	Perf Week	41.62%
Market Cap	339.04M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	0.00%	Shs Float	12.02M	Perf Month	61.74%
Income	-6.80M	PEG	-	EPS next Q	-0.14	Inst Own	6.20%	Short Float	2.00%	Perf Quarter	212.61%
Sales	12.30M	P/S	27.56	EPS this Y	25.30%	Inst Trans	0.11%	Short Ratio	1.20	Perf Half Y	378.97%
Book/sh	0.01	P/B	2232.00	EPS next Y	-10.40%	ROA	-34.10%	Target Price	18.00	Perf Year	330.89%
Cash/sh	0.97	P/C	23.06	EPS next 5Y	30.00%	ROE	-309.90%	52W Range	2.86 - 20.56	Perf YTD	40.47%
Dividend	-	P/FCF	-	EPS past 5Y	32.70%	ROI	-68.60%	52W High	8.56%	Beta	1.21
Dividend %	-	Quick Ratio	4.50	Sales past 5Y	25.50%	Gross Margin	74.00%	52W Low	680.39%	ATR	1.69
Employees	33	Current Ratio	5.40	Sales Q/Q	20.70%	Oper. Margin	-43.80%	RSI (14)	84.50	Volatility	14.51% 9.76%
Optionable	No	Debt/Eq	178.00	EPS Q/Q	-18.10%	Profit Margin	-55.60%	Rel Volume	2.76	Prev Close	19.39
Shortable	Yes	LT Debt/Eq	177.00	Earnings	-	Payout	-	Avg Volume	199.90K	Price	22.32
Recom	2.00	SMA20	40.03%	SMA50	81.36%	SMA200	245.24%	Volume	552,607	Change	15.11%

Jul-17-20

Initiated

B. Riley FBR

Buy

Jan-22-21 04:30PM	Shh! Commodity ETFs Quietly Rallying ETF.com +15.11%
Jan-14-21 04:05PM	ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe GlobeNewswire
Jan-12-21 04:05PM	ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results GlobeNewswire
Dec-29-20 04:15PM	ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms GlobeNewswire
Dec-28-20 12:13AM	How Does ClearPoint Neuro's (NASDAQ:CLPT) CEO Salary Compare to Peers? Simply Wall St. +7.38%
Dec-02-20 10:18AM	Silver ETFs Surge From Chart Support Investopedia
Nov-30-20 09:15AM	ClearPoint Neuro Completes 4,000th ClearPoint® Neuro Navigation Procedure GlobeNewswire
Nov-27-20 06:00AM	Silver Prices Are Set to Benefit From Surge in Solar Panels and 5G Barrons.com +5.94%
Nov-17-20 03:52PM	Best Commodities ETFs for Q1 2021 Investopedia
Nov-14-20 03:53PM	Why Buy Silver Now That Biden Is President Insider Monkey
Nov-13-20 05:41AM	What Kind Of Investors Own Most Of ClearPoint Neuro, Inc. (NASDAQ:CLPT)? Simply Wall St. +9.63%
05:31AM	Broker Revenue Forecasts For ClearPoint Neuro, Inc. (NASDAQ:CLPT) Are Surging Higher Simply Wall St.
Nov-12-20 12:25PM	Best Precious Metals ETFs for Q1 2021 Investopedia
Nov-10-20 04:05PM	ClearPoint Neuro Reports Third Quarter 2020 Results GlobeNewswire
02:30PM	Clearpoint Neuro, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-20 03:09PM	Best Silver ETFs for Q1 2021 Investopedia +5.26%
Nov-04-20 04:05PM	ClearPoint Neuro to Announce Third Quarter 2020 Results on November 10 GlobeNewswire
Oct-24-20 06:24PM	SLV Likely to Bring Pain And Rewards Investopedia
Sep-14-20 04:15PM	ClearPoint Neuro Announces Transition Plan for New Chief Financial Officer GlobeNewswire +16.48%
Aug-12-20 04:05PM	ClearPoint Neuro Reports Second Quarter 2020 Results GlobeNewswire
Aug-06-20 08:00AM	ClearPoint Neuro to Announce Second Quarter 2020 Results on August 12 GlobeNewswire
Jul-17-20 09:25AM	How Should Investors React To ClearPoint Neuro's (NASDAQ:CLPT) CEO Pay? Simply Wall St. +25.52%
May-12-20 04:05PM	ClearPoint Neuro Reports First Quarter 2020 Results GlobeNewswire
May-07-20 04:05PM	Corrected: ClearPoint Neuro to Announce First Quarter 2020 Results on May 12 GlobeNewswire
08:00AM	ClearPoint Neuro to Announce First Quarter 2020 Results on May 12 GlobeNewswire
Apr-17-20 08:10AM	Biotechnology Leader and Surgeon Dr. Matthew Klein Joins ClearPoint Neuro Board of Directors GlobeNewswire
Apr-16-20 08:00AM	ClearPoint Neuro Provides a COVID-19 Pandemic Update and Announces Preliminary First Quarter 2020 Financial Results GlobeNewswire -8.07%
Feb-14-20 08:55AM	ClearPoint Neuro, Inc. Announces 2020 Revenue Outlook Ahead of Nasdaq Investor Presentation Today GlobeNewswire

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience